U.S. Renewable Energy Stock News

In its latest quarter, AdaptHealth reported US$820.3 million in revenue, a 1.8% year-on-year increase that surpassed analyst estimates by 2.5%, with full-year revenue guidance matching expectations despite sector labor and reimbursement pressures. Although this was the slowest revenue growth among its senior health and home care peers, AdaptHealth’s ability to beat forecasts and reaffirm guidance highlights a measure of resilience in a challenging home-based care landscape. Next, we’ll...

Why Boston Scientific’s upcoming earnings are in focus Boston Scientific (BSX) is back on investor radar as the company approaches its next earnings release, with analysts lifting earnings estimates and pointing to solid demand in electrophysiology and structural heart procedures. See our latest analysis for Boston Scientific. At a share price of US$97.64, Boston Scientific has seen a 5.33% 1 month share price return and a 109.84% 3 year total shareholder return. This suggests underlying...

AbCellera Biologics (ABCL) has drawn fresh attention after settling a dispute with Bruker Corporation that brings in a US$36 million upfront payment plus future royalties, and it has also added scientist Stephen Quake to its board. See our latest analysis for AbCellera Biologics. The recent legal settlement and board appointment come on the back of a 7 day share price return of 27.41% and a year to date share price return of 27.41%. The 1 year total shareholder return of 49.66% contrasts with...

In recent weeks, Sysco Canada was named one of Atlantic Canada's Best Places to Work 2026, while Sysco Los Angeles began distributing Beyond Oil's product, and Sysco expanded its sustainability efforts through a partnership with Welgro Produce to support local growers. Together, these developments highlight how Sysco is combining workplace culture, product innovation, and supply-chain sustainability to reinforce its role in the foodservice ecosystem. We’ll now explore how Sysco’s new...

If you are wondering whether Salesforce shares are offering fair value right now, you are not alone. Many investors are asking the same question after recent price moves. The stock last closed at US$259.94, with returns of 2.5% over the past week, a 1.6% decline over 30 days, 2.5% year to date, a 17.7% decline over 1 year and a 76.0% and 23.4% return over 3 and 5 years respectively. Recent attention on Salesforce has centered on how the company is positioning its platform and tools within...

Recently, Thor Industries highlighted ongoing headwinds from a cooler recreational vehicle cycle, elevated interest rates, and uneven consumer demand that are pressuring its business conditions. An interesting twist is management’s use of pragmatic pricing in a highly competitive market, which could weigh on near-term margins as dealers keep inventories tight. With these pressures on RV demand and pricing in mind, we’ll now examine how the recent developments shape Thor Industries’...

If you are wondering whether Viking Therapeutics is still priced for promise or if the recent excitement has cooled enough to offer better value, this article walks you through what the current price might be implying. The stock has recently given back some ground, with a 9.7% decline over the last week, a 14.8% decline over the last month, and an 18.6% decline over the past year. The 3-year and 5-year returns sit at 257.4% and 393.7% respectively. These moves sit against a backdrop of...

In recent days, UBS initiated coverage on IDEAYA Biosciences and the company reported full enrollment of its pivotal Phase 2/3 darovasertib trial in metastatic uveal melanoma, while GlaxoSmithKline opted to end their collaboration and return the Werner Helicase and Pol Theta programs by March 2026. This combination of fresh analyst attention, approaching pivotal data, and regained control of key oncology assets reshapes how investors may view IDEAYA’s pipeline breadth and future...

If you are wondering whether Yum! Brands at around US$155 a share is still good value after its recent run, you are not alone. The stock has returned 3.3% over the last week, 5.0% over the last month, 3.3% year to date and 28.6% over the past year, with a 5 year return of 60.1%. Recent attention on Yum! Brands has focused on how its global fast food brands fit into consumer spending trends and how investors are weighing that against other consumer services stocks. This backdrop helps explain...

In recent days, Mondelez International has moved to review its U.S. creative agencies following the appointment of Travis Freeman as senior vice president and global head of consumer experience, while investors focus on its soon-to-be-reported fourth-quarter results against a backdrop of higher input costs and softer demand. This combination of a fresh marketing leadership direction and upcoming earnings has sharpened attention on how Mondelez positions its brands and manages cost...

Carter’s, Inc. recently appointed David B. Tichiaz as Chief Brand Officer, placing him in charge of product design and merchandising after leadership roles at Stance and Vans. This hire brings fresh apparel and lifestyle brand expertise that could influence how Carter’s refreshes its product offering while it continues to close lower-margin stores. Now we’ll explore how bringing in a seasoned lifestyle brand leader to oversee design and merchandising could reshape Carter’s broader investment...

Barclays’ upgrade of Lowe's Companies (LOW) to overweight puts fresh attention on the retailer, as the bank points to valuation, pent up demand, housing trends, and tax policy as key drivers. See our latest analysis for Lowe's Companies. At a share price of US$267.21, Lowe's has seen momentum build recently, with a 1 day share price return of 4.29% and a 90 day share price return of 15.07%. The 5 year total shareholder return of 70.99% points to meaningful long term value creation. If this...

In early January 2026, Krystal Biotech reported a positive interim update from the highest-dose cohort of its Phase 1 CORAL-1 study of inhaled gene therapy KB407 in cystic fibrosis, confirming successful lung delivery and expression of wild-type CFTR protein with generally mild to moderate side effects and one procedure-related serious adverse event that resolved. The company also disclosed that it has submitted the design of its repeat-dosing CORAL-3 study to the US FDA, aiming to advance...

If you are wondering whether Nextpower's recent share price puts it at a bargain or a stretch, you are not alone. This article will walk through what the current price might be implying. Nextpower shares closed at US$91.17, with a 121.8% return over the last year, a 2.0% gain over the past month, and a 1.7% decline over the last week. This has naturally raised questions about how the market is weighing its potential against its risks. Recent coverage has focused on Nextpower's position in...

If you are wondering whether Organon is a bargain or a value trap at around US$8.05, this article walks through what the current share price might be telling you about the stock. The share price has moved by 11.2% over the last week and 12.1% over the last month, although the 1 year return stands at a 47.9% decline and the 3 year return at a 70.9% decline. Recent attention on Organon has focused on its position in the pharmaceuticals and biotech space and how investors are reassessing...

If you are wondering whether PACCAR's current share price still offers value, you are not alone. The stock has been attracting plenty of attention from investors looking for quality industrial names. PACCAR shares last closed at US$118.80, with returns of 6.5% over the past week, 4.7% over the past month, 6.5% year to date, 14.4% over 1 year, 94.1% over 3 years and 143.5% over 5 years, giving investors plenty to think about when they look at the current price. Recent headlines around PACCAR...

Piper Sandler’s recent upgrade of HF Sinclair (DINO), highlighting its West Coast exposure and refining sector optimism, has pushed the stock into focus for investors watching how sentiment lines up with current fundamentals. See our latest analysis for HF Sinclair. That upgrade sits against a mixed price backdrop, with the share price at US$50.30 after a 7.4% 7 day share price return and a modest year to date share price gain. The 1 year total shareholder return of 47.3% signals strong...

If you are wondering whether Aptiv's current share price reflects its true worth, you are not alone. The stock has drawn fresh attention from investors trying to work out if it is priced attractively or not. Aptiv shares recently closed at US$88.67, with returns of 13.0% over the past week, 12.9% over the past month, 13.0% year to date, and a 49.4% gain over the last year, alongside 3 year and 5 year returns of 12.7% and 37.9% declines. These mixed return figures have put a spotlight on how...

GDS Holdings (GDS) is back in focus after its subsidiary DayOne Data Centers secured more than US$2b in Series C equity financing to accelerate hyperscale expansion across Europe and key Asia Pacific markets. See our latest analysis for GDS Holdings. The hyperscale funding news has arrived after a strong run, with GDS Holdings posting a 23.0% 90 day share price return and a 53.16% 1 year total shareholder return. However, the 5 year total shareholder return of a 61.00% decline shows longer...

SkyWater Technology (SKYT) is back on traders’ radar after short interest climbed and the share price slipped 2.67% even as the broader market moved higher, with analysts also expecting revenue growth. See our latest analysis for SkyWater Technology. That recent pullback sits against a sharp rebound in momentum, with the 30 day share price return at 52.71% and the 90 day share price return at 66.46%, while the 1 year total shareholder return is 148.15%. This suggests sentiment has shifted...

In recent days, Park Hotels & Resorts announced its latest Corporate Responsibility Report and received a Prime ISS ESG rating alongside multiple Newsweek recognitions, while also outlining plans for additional LEED certifications and a solar PV project at Hilton Waikoloa Village in 2026. At the same time, Barclays began covering Park Hotels & Resorts with a positive view focused on portfolio reshaping and de-leveraging, following approximately US$198,000,000 of non-core hotel sales that...

If you are wondering whether Archer Aviation’s share price still offers value after a volatile few years, this article explains what the current market price could be implying. The stock recently closed at US$8.81, with returns of 8.4% over the past week, 5.3% over the last month, an 8.4% gain year to date and a 1.8% decline over the last year. These moves come as Archer continues to attract attention in the emerging electric air taxi space and remains a regular feature in broader...

In early January 2026, Regal Rexnord gained fresh attention as investors shifted out of technology names and into industrial companies expected to benefit from government spending and steadier energy costs. This rotation highlighted Regal Rexnord’s position within heavy industry as investors searched for businesses aligned with policy-driven demand and infrastructure-related projects. We’ll now examine how the rotation into industrials on anticipated government spending may influence Regal...

On January 7, 2026, Rumble Inc. and Tether launched Rumble Wallet, a non-custodial crypto wallet embedded in the Rumble platform that lets users tip creators directly in Bitcoin, Tether (USDT), and Tether Gold (XAUt), with MoonPay powering conversion between crypto and traditional payment methods. By removing banks, ad networks, and other intermediaries from creator payouts, Rumble Wallet introduces a parallel, crypto-native monetization track that could materially reshape how value flows...